The Psoriasis HealthPathway was localised in September 2020.
Psoriasis vulgaris is the medical name for the most common form of psoriasis (“vulgaris” meaning common). Over 1.6 million Australians are living with the condition.
The background section of the Psoriasis HealthPathway advises that the disorder has a genetic susceptibility. It can begin at any age, with peak onset between 30 and 39 years and between 50 and 69 years. There is no reliable cure for the condition. The primary goal of treatment advised is to induce remission or control activity to a tolerable level, relieve symptoms, improve quality of life and identify and treat comorbidities. Common triggers are also listed in this section.
The assessment section guides clinicians to take the patient’s history, assess psychological impact, assess for associated psoriatic arthritis, examine the patient, look at considering a differential diagnoses, determine the clinical subtypes listed when making the diagnoses and investigations to consider undertaking.
The management section provides a guide of when to request an urgent dermatology assessment. There is also information about education on the diagnosis, treating or modifying known triggers (which are listed), skin care and suggests discussing and deciding with the patient the best therapy to undertake. There are also further suggested management guidelines listed.
The referral section has an option to refer the patient for an acute and non-acute dermatology assessment and advises when to refer for a non-acute rheumatology and/or ophthalmology assessment.
For a list of all localised pathways see:
Mid and North Coast HealthPathways
Username: manchealth
Password: conn3ct3d
For further information about HealthPathways contact:
- Fiona Ryan (MNC) [email protected]
- Kerrie Keyte (NNSW) [email protected]